Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts.

PubWeight™: 0.96‹?› | Rank: Top 15%

🔗 View Article (PMID 2999181)

Published in J Clin Endocrinol Metab on January 01, 1986

Authors

P D Lee, R G Rosenfeld, R L Hintz, S D Smith

Articles citing this

Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type 1 insulin-like growth factor receptor. Proc Natl Acad Sci U S A (1993) 2.58

Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver. J Clin Invest (1988) 1.40

Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases? Pharmacol Rev (2010) 1.39

Inhibition of growth, production of insulin-like growth factor-II (IGF-II), and expression of IGF-II mRNA of human cancer cell lines by antagonistic analogs of growth hormone-releasing hormone in vitro. Proc Natl Acad Sci U S A (1999) 1.16

Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone. J Clin Invest (1988) 1.02

Roles of insulinlike growth factor 1 (IGF-1) and the IGF-1 receptor in epidermal growth factor-stimulated growth of 3T3 cells. Mol Cell Biol (1992) 0.99

Inhibition of type I insulin-like growth factor receptor tyrosine kinase by picropodophyllin induces apoptosis and cell cycle arrest in T lymphoblastic leukemia/lymphoma. Leuk Lymphoma (2014) 0.78

Type I insulin-like growth factor receptor signaling in hematological malignancies. Oncotarget (2017) 0.76

The coexistence of an intrasellar adenoma, lymphocytic hypophysitis, and primary pituitary lymphoma in a patient with acromegaly. Case Rep Endocrinol (2011) 0.75

Articles by these authors

TAN-1, the human homolog of the Drosophila notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms. Cell (1991) 10.06

Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell (1986) 7.34

Quantitative trait locus for reading disability on chromosome 6. Science (1994) 6.07

Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell (1990) 4.60

Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc Natl Acad Sci U S A (1988) 4.40

Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell lines. Cancer Res (1984) 3.67

Homozygous deletion of the alpha- and beta 1-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci U S A (1988) 3.67

The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev (1999) 3.54

Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukemias. Proc Natl Acad Sci U S A (1991) 3.25

Two-year results of treatment with depot leuprolide acetate for central precocious puberty. J Pediatr (1992) 2.93

lyl-1, a novel gene altered by chromosomal translocation in T cell leukemia, codes for a protein with a helix-loop-helix DNA binding motif. Cell (1989) 2.84

Novel mutations in the connexin 26 gene (GJB2) that cause autosomal recessive (DFNB1) hearing loss. Am J Hum Genet (1998) 2.51

Quantitative-trait locus for specific language and reading deficits on chromosome 6p. Am J Hum Genet (1999) 2.26

Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science (1992) 2.19

Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. J Clin Endocrinol Metab (1998) 2.17

TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch Ophthalmol (1997) 2.11

Linkage of autosomal dominant hearing loss to the short arm of chromosome 1 in two families. N Engl J Med (1994) 2.03

Differential phosphorylation and localization of the transcription factor UBF in vivo in response to serum deprivation. In vitro dephosphorylation of UBF reduces its transactivation properties. J Biol Chem (1992) 2.02

ESPE/LWPES consensus statement on diabetic ketoacidosis in children and adolescents. Arch Dis Child (2004) 2.01

A reliable method for evaluating drug compliance in children with cancer. Cancer (1979) 2.00

Common region on chromosome 14 in T-cell leukemia and lymphoma. Science (1984) 1.98

Specific reading disability: identification of an inherited form through linkage analysis. Science (1983) 1.94

Genetic influences on learning disabilities and speech and language disorders. Child Dev (1983) 1.90

Identification of a family of low-affinity insulin-like growth factor binding proteins (IGFBPs): characterization of connective tissue growth factor as a member of the IGFBP superfamily. Proc Natl Acad Sci U S A (1997) 1.88

Fusion of an immunoglobulin variable gene and a T cell receptor constant gene in the chromosome 14 inversion associated with T cell tumors. Cell (1985) 1.87

Insulin-like growth factor-binding proteins (IGFBPs) and their regulatory dynamics. Int J Biochem Cell Biol (1996) 1.84

Insertion sequence elements of Pseudomonas savastanoi: Nucleotide sequence and homology with Agrobacterium tumefaciens transfer DNA. Proc Natl Acad Sci U S A (1986) 1.77

The somatomedins: a family of insulinlike hormones under growth hormone control. Recent Prog Horm Res (1974) 1.76

Analysis of the phosphorylation, DNA-binding and dimerization properties of the RNA polymerase I transcription factors UBF1 and UBF2. Nucleic Acids Res (1992) 1.69

Bone mineral, histomorphometry, and body composition in adults with growth hormone receptor deficiency. J Bone Miner Res (1998) 1.69

Recommendations for nomenclature of the insulin-like growth factor binding protein superfamily. Endocrinology (1998) 1.66

Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL). Science (1988) 1.59

Insulin-like growth factors and their binding proteins in the term and preterm human fetus and neonate with normal and extremes of intrauterine growth. J Clin Endocrinol Metab (1995) 1.59

Both human pituitary growth hormone and recombinant DNA-derived human growth hormone cause insulin resistance at a postreceptor site. J Clin Endocrinol Metab (1982) 1.59

A long-term dose-response study of mitomycin in glaucoma filtration surgery. Arch Ophthalmol (1997) 1.58

Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7. Recombinant human mac25 protein specifically binds IGF-I and -II. J Biol Chem (1996) 1.58

Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia. Proc Natl Acad Sci U S A (1988) 1.56

Prospective clinical trial of human growth hormone in short children without growth hormone deficiency. J Pediatr (1984) 1.55

A chromosome 14 inversion in a T-cell lymphoma is caused by site-specific recombination between immunoglobulin and T-cell receptor loci. Nature (1986) 1.55

Ahmed glaucoma valve implant vs trabeculectomy in the surgical treatment of glaucoma: a randomized clinical trial. Am J Ophthalmol (2000) 1.54

Mutations in the KCNQ4 gene are responsible for autosomal dominant deafness in four DFNA2 families. Hum Mol Genet (1999) 1.54

Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab (1992) 1.53

A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis. J Urol (1999) 1.53

Spontaneous serum gonadotropin concentrations in the evaluation of precocious puberty. J Pediatr (1995) 1.52

Prospective results of a standardized algorithm based on hemodynamic status for managing pediatric solid organ injury. J Am Coll Surg (2001) 1.50

Explorations of the insulinlike and growth-promoting properties of somatomedin by membrane receptor assays. Adv Metab Disord (1975) 1.49

Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J Biol Chem (1993) 1.49

Treatment of CNS relapse in children with acute lymphoblastic leukemia: A Pediatric Oncology Group study. J Clin Oncol (1993) 1.45

A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia. Nature (1987) 1.42

rUBF, an RNA polymerase I transcription factor from rats, produces DNase I footprints identical to those produced by xUBF, its homolog from frogs. Mol Cell Biol (1990) 1.41

The gene for enhancer binding proteins E12/E47 lies at the t(1;19) breakpoint in acute leukemias. Science (1989) 1.41

Mononuclear blood cell magnesium content and serum magnesium concentration in critically ill hypomagnesemic patients after replacement therapy. Nutrition (1997) 1.41

Bacterial infection induces nitric oxide synthase in human neutrophils. J Clin Invest (1997) 1.40

Insulin-like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab (1991) 1.40

Obtaining an accepted Investigational New Drug application to operate an umbilical cord blood bank. Transfusion (1999) 1.39

Testicular temperatures measured by thermistor probe and contact thermography. Fertil Steril (1990) 1.39

Quantitative trait locus for reading disability: correction. Science (1995) 1.37

Phonological processing skills and deficits in adult dyslexics. Child Dev (1990) 1.35

Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab (1996) 1.34

Hypoxia limits differentiation and up-regulates expression and activity of prostaglandin H synthase 2 in cultured trophoblast from term human placenta. Am J Obstet Gynecol (1999) 1.33

Somatomedin-C mediates growth hormone negative feedback by effects on both the hypothalamus and the pituitary. Science (1981) 1.33

Insulin inhibits transcription of the human gene for insulin-like growth factor-binding protein-1. J Biol Chem (1991) 1.32

Evidence for linkage and association with reading disability on 6p21.3-22. Am J Hum Genet (2002) 1.31

Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group. J Clin Endocrinol Metab (2000) 1.26

Cytotoxic T lymphocytes specific for self tumor immunoglobulin express T cell receptor delta chain. J Exp Med (1989) 1.26

Normal ranges for immunochemiluminometric gonadotropin assays. J Pediatr (1995) 1.26

Analysis of DNA surrounding the breakpoints of chromosomal translocations involving the beta T cell receptor gene in human lymphoblastic neoplasms. Cell (1987) 1.26

Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients. J Clin Endocrinol Metab (1993) 1.26

Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. J Endocrinol (1994) 1.25

Apoptosis in human cultured trophoblasts is enhanced by hypoxia and diminished by epidermal growth factor. Am J Physiol Cell Physiol (2000) 1.25

Insulin-like growth factor binding protein 3 mediates retinoic acid- and transforming growth factor beta2-induced growth inhibition in human breast cancer cells. Cancer Res (1996) 1.25

Short stature and pubertal delay in male adolescents with cystic fibrosis. Androgen treatment. Am J Dis Child (1984) 1.23

Inhibition of insulin receptor activation by insulin-like growth factor binding proteins. J Biol Chem (1997) 1.23

Diagnostic controversy: the diagnosis of childhood growth hormone deficiency revisited. J Clin Endocrinol Metab (1995) 1.21

Familial holoprosencephaly with endocrine dysgenesis. J Pediatr (1968) 1.21

Common mechanism of chromosome inversion in B- and T-cell tumors: relevance to lymphoid development. Science (1986) 1.21

Insulin-infusion-pump treatment of diabetes: influence of improved metabolic control on plasma somatomedin levels. N Engl J Med (1981) 1.21

Virilizing adrenocortical tumors in childhood: eight cases and a review of the literature. Pediatrics (1985) 1.20

Hypoxia reduces expression and function of system A amino acid transporters in cultured term human trophoblasts. Am J Physiol Cell Physiol (2002) 1.20

Demonstration of specific plasma protein binding sites for somatomedin. J Clin Endocrinol Metab (1977) 1.19

Genetics of performance in the horse. J Anim Sci (1980) 1.19

Treatment of Turner's syndrome with recombinant human growth hormone (somatrem). Acta Paediatr Scand Suppl (1988) 1.19

Binding properties and distribution of insulin-like growth factor binding protein-related protein 3 (IGFBP-rP3/NovH), an additional member of the IGFBP Superfamily. J Clin Endocrinol Metab (1999) 1.19

Insulin resistance due to a defect distal to the insulin receptor: demonstration in a patient with leprechaunism. Proc Natl Acad Sci U S A (1978) 1.18

Characterization of the somatomedin-C/insulin-like growth factor I (SM-C/IGF-I) receptor on cultured human fibroblast monolayers: regulation of receptor concentrations by SM-C/IGF-I and insulin. J Clin Endocrinol Metab (1982) 1.18

Absence of cell surface LFA-1 as a mechanism of escape from immunosurveillance. Lancet (1987) 1.18

Competitive binding of somatomedin to the insulin receptors of adipocytes, chondrocytes, and liver membranes. Proc Natl Acad Sci U S A (1972) 1.18

Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation. Pediatr Res (1986) 1.17

Rb and p130 regulate RNA polymerase I transcription: Rb disrupts the interaction between UBF and SL-1. Oncogene (2000) 1.17

Transforming growth factor-beta-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J Biol Chem (1995) 1.17

Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule. Endocrinology (1999) 1.16

Insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) is a potential tumor suppressor protein for prostate cancer. Cancer Res (1999) 1.16

Further delineation of aortic dilation, dissection, and rupture in patients with Turner syndrome. Pediatrics (1998) 1.15

Evidence for major gene transmission of developmental dyslexia. JAMA (1991) 1.15

Does the GH-IGF axis play a role in cancer pathogenesis? Growth Horm IGF Res (2000) 1.14